FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 201 through 250 of 302

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
NUVL Nasdaq Nuvalent, Inc. 2836
NVCT Nasdaq Nuvectis Pharma, Inc. 2836
NVO New York Novo Nordisk A/S 2836
NVS New York Novartis AG 2836
NXTC Nasdaq NextCure, Inc. 2836
OABI Nasdaq OmniAb, Inc. 2836
OCUL Nasdaq Ocular Therapeutix, Inc. 2836
OKUR Nasdaq OnKure Therapeutics, Inc. 2836
OKYO Nasdaq OKYO Pharma Limited 2836
ONCO Nasdaq Onconetix, Inc. 2836
ONCY Nasdaq Oncolytics Biotech Inc. 2836
ORGO Nasdaq Organogenesis Holdings Inc. 2836
ORKA Nasdaq Oruka Therapeutics, Inc. 2836
OTLK Nasdaq Outlook Therapeutics, Inc. 2836
OVID Nasdaq Ovid Therapeutics Inc. 2836
PACB Nasdaq Pacific Biosciences of California, Inc. 2836
PGEN Nasdaq Precigen, Inc. 2836
PHGE NYSE American BiomX Inc. 2836
PMVP Nasdaq PMV Pharmaceuticals, Inc. 2836
PRAX Nasdaq Praxis Precision Medicines, Inc. 2836
PRLD Nasdaq Prelude Therapeutics Incorporated 2836
PRME Nasdaq Prime Medicine, Inc. 2836
PTGX Nasdaq Protagonist Therapeutics, Inc. 2836
PURR Nasdaq Hyperliquid Strategies Inc. 2836
PVLA Nasdaq Palvella Therapeutics, Inc. 2836
QNCX Nasdaq Quince Therapeutics, Inc. 2836
QNRX Nasdaq Quoin Pharmaceuticals, Ltd. 2836
QTTB Nasdaq Q32 Bio Inc. 2836
QURE Nasdaq uniQure N.V. 2836
RANI Nasdaq Rani Therapeutics Holdings, Inc. 2836
RAPP Nasdaq Rapport Therapeutics, Inc. 2836
RAPT Nasdaq RAPT Therapeutics, Inc. 2836
RARE Nasdaq Ultragenyx Pharmaceutical Inc. 2836
RCUS New York Arcus Biosciences, Inc. 2836
REGN Nasdaq Regeneron Pharmaceuticals, Inc. 2836
REPL Nasdaq Replimune Group, Inc. 2836
RGNT NYSE American Regentis Biomaterials Ltd. 2836
RLAY Nasdaq Relay Therapeutics, Inc. 2836
RLYB Nasdaq Rallybio Corporation 2836
RNAM Nasdaq Avidity Biosciences, Inc. 2836
RNXT Nasdaq RenovoRx, Inc. 2836
ROIV Nasdaq Roivant Sciences Ltd. 2836
RVMD Nasdaq Revolution Medicines, Inc. 2836
RZLT Nasdaq Rezolute, Inc. 2836
SANA Nasdaq Sana Biotechnology, Inc. 2836
SCNI Nasdaq Scinai Immunotherapeutics Ltd. 2836
SEPN Nasdaq Septerna, Inc. 2836
SER NYSE American Serina Therapeutics, Inc. 2836
SGMT Nasdaq Sagimet Biosciences Inc. 2836
SILO Nasdaq Silo Pharma, Inc. 2836
Results 200 through 250 of 302